Am J Transplant, Volume 18, Suppl 3 Archives - Page 19 of 211 - ATC Abstracts

2018 American Transplant Congress
Interstitial Inflammation is Correlated with DQ Antibodies in Kidney Transplant Recipients
C. Harris, L. Anderson, R. Khaim, J. Choudhuri, R. Shapiro, S. Florman, F. Salem, M. Menon.
Icahn School of Medicine at Mount Sinai, New York.
Background: Studies have shown that borderline rejection (BR) and acute cellular rejection (ACR) often co-occur with antibody-mediated rejection (AMR). We examined the association between interstitial…
2018 American Transplant Congress
Decreased Clinical Significance of Isoagglutinin Titer with the Current Desensitization Protocol in ABO-Incompatible Kidney Transplantation
C. Baek, H. Kim, W. Yang, D. Han, S-.K. Park.
Department of Internal Medicine, Division of Nephrology, Asan Medical Center, Seoul, Republic of Korea; Department of Surgery, Asan Medical Center, Seoul, Republic of Korea.
ABO-incompatible (ABOi) kidney transplantation (KT) has become a routine procedure with graft survival rates comparable to those of ABO-compatible KT. However, the clinical significance of…
2018 American Transplant Congress
Evaluation of KPD: Does It Improve Overall Transplant Center Performance?
M. Rees,³ E. Michelin,¹ N. Koizumi,² J. Ortiz.³
¹West Virginia School of Osteopathic Medicine, Lewisburg, WV; ²George Mason University, Fairfax, VA; ³University of Toledo College of Medicine, Toledo, OH.
Introduction: The medical community is facing a constant shortage of kidneys for transplant patients. The most effective way to combat the deficit is to increase…
2018 American Transplant Congress
Relation between Seroprevalence of Cytomegalovirus and Graft Survival in Japanese Kidney Transplant Recipients: The Japan Academic Consortium of Kidney Transplantation Study
K. Miyake,^1,2 M. Okumi,¹ K. Unagami,³ Y. Kakuta,¹ H. Shirakawa,⁴ K. Omoto,⁵ H. Ishida,¹ K. Tanabe.¹
¹Urology, Tokyo Women's Medical University, Tokyo, Japan; ²Kidney Transplantation, Shonan Kamakura General Hospital, Kamakura, Japan; ³Nephrology, Tokyo Women's Medical University, Tokyo, Japan; ⁴Urology, Okubo Hospital, Tokyo, Japan; ⁵Urology, Toda Chuo General Hospital, Saitama, Japan.
BackgroundCytomegalovirus (CMV) infection is one of major causes of morbidity in kidney transplant recipients (KTRs). However, the current prevalence of CMV in KTRs and the…
2018 American Transplant Congress
Clinical Validation of a Novel ELISpot-Based In Vitro Diagnostic Assay to Monitor CMV-Specific Cell-Mediated Immunity in Kidney Transplant Recipients
B. Banas,¹ D. Steubl,² L. Renders,² D. Chittka,¹ M. Banas,¹ T. Wekerle,³ M. Koch,⁴ O. Witzke,⁵ A. Muehlfeld,⁶ C. Sommerer,⁷ A. Habicht,⁸ C. Hugo,⁹ T. Huenig,¹⁰ M. Lindemann,⁵ T. Schmidt,¹¹ A. Rascle,¹¹ S. Barabas,¹¹ L. Deml,¹¹ R. Wagner,^1,11 B. Kraemer,¹² B. Krueger.¹²
¹University Clinic, Regensburg, Germany; ²Clinic rechts der Isar TUM, Munich, Germany; ³Medical University, Vienna, Austria; ⁴University Clinic, Hamburg-Eppendorf, Germany; ⁵University Hospital, Essen, Germany; ⁶Uniklinik RWTH, Aachen, Germany; ⁷University Hospital, Heidelberg, Germany; ⁸LMU Medical Center, Munich, Germany; ⁹University Hospital, Dresden, Germany; ¹⁰University Hospital, Wuerzburg, Germany; ¹¹Lophius Biosciences, Regensburg, Germany; ¹²UMM Uni. Heidelberg, Mannheim, Germany.
Impaired cytomegalovirus (CMV)-specific cell-mediated immunity (CMV-CMI) is a major cause ofCMV reactivation and associated complications in solid-organ transplantation. Reliably assessing CMV-CMI is desirable to individually…
2018 American Transplant Congress
Evaluation of Salt Intake by 24-h Urinary Sodium Excretion in Kidney Transplant Patients
T. Abe,¹ M. Kawamura,¹ S. Nakazawa,¹ T. Kato,¹ R. Imamura,¹ N. Ichimaru,² S. Takahara,² N. Nonomura.¹
¹Departments of Urology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan; ²Departments of Advanced Technology for Transplantation, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Background: Dietary recommendations for chronic kidney disease advise 3 to 6 g/day of dietary salt intake. We evaluated current adherence to dietary recommendations for CKD…
2018 American Transplant Congress
Malignancy Complications after Kidney Transplantation, the Role of Immunosuppression
M. Molina,¹ J. Cabrera,² E. Gonzalez,¹ A. Hernández,¹ N. Polanco,¹ A. Andres.¹
¹Nephrology Department, Hospital Universitario 12 de Octubre, Madrid, Spain; ²Nephrology Department, Hospital Evangelico, Montevideo, Uruguay.
Introduction: Immunosuppression therapy is essential to avoid rejection after kidney transplantation. The chronic use of this drugs increases the risk of malignancy compared to general…
2018 American Transplant Congress
The Initial Hepatic Artery Reperfusion versus Initial Portal Reperfusion in Liver Transplantation: Where Do We Stand?
R. Shahbazov,¹ F. Azari,³ J. Alejo,² M. Talanian,² M. Fox,² K. Kennedy,² S. Kessel,² A. Nickkholgh,¹ D. Maluf,¹ S. Pelletier.¹
¹Surgery, University of Virginia Health System, Charlottesville, VA; ²School of Medicine, University of Virginia Health System, Charlottesville, VA; ³Surgery, University of Pennsylvania Medical Center, Philadelphia, PA.
Introduction: While initial portal vein reperfusion (PVRP) of a liver allograft is nearly standardized, limited data suggests initial hepatic arterial reperfusion (HARP) may improve hemodynamics…
2018 American Transplant Congress
Early Biliary Complications after Orthotopic Liver Transplantation – Non-Randomised Comparison of 3 Methods of Biliary Tract Drainage
A. Jóźwik,¹ M. Kosieradzki,¹ B. Łągiewska,¹ W. Lisik,¹ E. Karpeta,¹ J. Bednarek,² M. Zaborska,² J. Trzebicki,³ M. Pacholczyk.¹
¹Department of General and Transplantation Surgery, Medical University of Warsaw, Warsaw, Poland; ²Medical University of Warsaw, Warsaw, Poland; ³I Department of Anaesthesiology and Intensive Care, Medical University of Warsaw, Warsaw, Poland.
BackgroundBiliary tract complications (BTC) are still relatively common and complex problem following orthotopic liver transplantation (OLT). The aim of this nonrandomized study was to evaluate…
2018 American Transplant Congress
Large Decrease in Liver Waiting List Dropout Rate for MELD > 14
D. Schladt,¹ J. Pyke,¹ A. Israni,¹ W. Kim,² J. Lake,³ J. Snyder.¹
¹SRTR, Minneapolis; ²Stanford University, Stanford; ³Univ of Minnesota, Minneapolis.
Median MELD at transplant has increased steadily over the past 10 years. One possible mechanism is decreased waitlist dropout rates, particularly among liver candidates with…